Medical Xpress news
Medical Xpress / A potential replacement for bone marrow sampling: New blood test may detect leukemia risk
What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in-depth studies into ...
Medical Xpress / Partial match parity: Increasing the donor pool for hematopoietic stem cell transplantation
Blood cancer patients who may have previously struggled to find a donor for transplantation now have more options. A new study shows that patients achieve good outcomes with a partial match drawn from the national public ...
Medical Xpress / Two classes of FOXA1 mutations found to drive prostate cancer and therapy resistance
A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer—drive tumor initiation ...
Medical Xpress / Food and housing insecurity linked to unsafe gun storage
Tarang Parekh was getting ready for work at his apartment in Houston, Texas, in 2022, when he heard gunfire. He'd never heard the sound before, except on TV, but instantly recognized it. He ran downstairs and saw a gruesome ...
Medical Xpress / New credit card-sized TB test could close the diagnostic gap in HIV hotspots
Current tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests by eliminating the immune cells relied upon to sound the alarm.
Medical Xpress / Releasing a molecular 'brake' may help immune cells better fight cancer
Van Andel Institute scientists and collaborators have discovered a potential treatment target that may re-energize dysfunctional or "exhausted" immune cells in their fight against cancer.
Medical Xpress / Molecular mapping reveals how benign borderline ovarian tumors become invasive
Low-grade serous ovarian cancer (LGSC), accounts for just 5% to 10% of all epithelial ovarian cancers, but its distinct biology makes it especially challenging to treat. While the origin of this disease has not been identified, ...
Medical Xpress / When B-cells turn cancerous may decide fate of childhood leukemia treatment
A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL).
Medical Xpress / Majority of Medicaid managed care plans cover opioid overdose reversal drug naloxone, but access barriers remain
A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose reversal drug naloxone, although certain restrictions and quantity limits may still prevent people from ...
Medical Xpress / Brain imaging benchmark could better classify Alzheimer's disease-related changes
A team of researchers from the Keck School of Medicine of USC's Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) has identified a new brain imaging benchmark that may improve how researchers classify ...
Medical Xpress / Study identifies ways to lower risk of liver cancer for people with hepatitis B infection
Hepatitis B virus (HBV) infection is known to be associated with the risk of hepatocellular carcinoma (HCC), but how and why they are connected remains unknown. Researchers from Mass General Brigham discovered that HBV does ...
Medical Xpress / Genomics software processes datasets 100 times faster than current tools to advance cancer research
A new tool—seen as the Google Earth for genomics—will transform how scientists visualize and analyze genomic data, advancing cancer research techniques.
